[A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment]

Lakartidningen. 2008 Oct;105(42):2917-22.
[Article in Swedish]
No abstract available

MeSH terms

  • Biomedical Research / standards
  • Cost-Benefit Analysis
  • Drug Approval
  • Drug Costs / trends
  • Drug Discovery* / economics
  • Drug Discovery* / standards
  • Drug Evaluation / methods*
  • Drug Industry / standards
  • Drugs, Investigational* / economics
  • Drugs, Investigational* / therapeutic use
  • Forecasting
  • Humans
  • International Cooperation
  • Product Surveillance, Postmarketing
  • Quality Assurance, Health Care
  • Safety

Substances

  • Drugs, Investigational